XML 102 R83.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Investments in and Advances to Unconsolidated Joint Ventures - Schedule of Equity Method Investments (Details) $ in Thousands | Dec. 31, 2018 USD ($) joint_venture | Dec. 31, 2017 USD ($) | Jan. 31, 2017 USD ($)
--- | --- | --- | ---
Schedule of Equity Method Investments [Line Items] |  |  |
Advances to unconsolidated joint ventures, net | $ 71 | $ 226 |
Investments in and advances to unconsolidated joint ventures | $ 540,088 | 800,840 |
CCRC JV |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Investment ownership percentage | 49.00% |  |
Equity method investments | $ 365,764 | 400,241 |
RIDEA II |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Investment ownership percentage | 40.00% |  | 40.00%
Equity method investments | $ 0 | 259,651 | $ 121,000
U.K. JV |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Investment ownership percentage | 49.00% |  |
Equity method investments | $ 101,735 | 0 |
Life Science JVs |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Equity method investments | $ 0 | 65,581 |
Life Science JVs | Minimum |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Investment ownership percentage | 50.00% |  |
Life Science JVs | Maximum |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Investment ownership percentage | 63.00% |  |
Torrey Pines Science Center |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Investment ownership percentage | 50.00% |  |
Britannia Biotech Gateway, LP |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Investment ownership percentage | 55.00% |  |
LASDK, LP |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Investment ownership percentage | 63.00% |  |
MBK JV |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Investment ownership percentage | 50.00% |  |
Equity method investments | $ 35,435 | 38,005 |
Unconsolidated development joint ventures |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Equity method investments | $ 25,493 | 23,365 |
Number of unconsolidated joint ventures (in joint ventures) | joint_venture | 4 |  |
Unconsolidated development joint ventures | Minimum |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Investment ownership percentage | 50.00% |  |
Unconsolidated development joint ventures | Maximum |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Investment ownership percentage | 90.00% |  |
Vintage Park Development JV |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Investment ownership percentage | 85.00% |  |
Waldwick |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Investment ownership percentage | 85.00% |  |
Otay Ranch |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Investment ownership percentage | 90.00% |  |
MBK Development JV |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Investment ownership percentage | 50.00% |  |
Medical Office JVs |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Equity method investments | $ 10,160 | 12,488 |
Number of unconsolidated joint ventures (in joint ventures) | joint_venture | 3 |  |
Medical Office JVs | Minimum |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Investment ownership percentage | 20.00% |  |
Medical Office JVs | Maximum |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Investment ownership percentage | 67.00% |  |
HCP Ventures IV, LLC |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Investment ownership percentage | 20.00% |  |
H C P Ventures III, LLC |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Investment ownership percentage | 30.00% |  |
Suburban Properties, LLC |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Investment ownership percentage | 67.00% |  |
K&Y JVs |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
Investment ownership percentage | 80.00% |  |
Equity method investments | $ 1,430 | $ 1,283 |
Number of unconsolidated joint ventures (in joint ventures) | joint_venture | 3 |  |

X
- Definition Represents number of unconsolidated joint ventures between entity and an institutional capital partner. + References No definition available. + Details
Name: | hcp_NumberOfUnconsolidatedJointVenture
Namespace Prefix: | hcp_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Long-Term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership. This does not include advances to clients. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04.2) -URI http://asc.fasb.org/extlink&oid=6488278&loc=d3e603758-122996 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 4 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6812-107765 + Details
Name: | us-gaap_AdvancesToAffiliate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.12) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_EquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of investment in equity method investee and investment in and advance to affiliate. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.12) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_CcrcJvInvestmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_Ridea2Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_U.K.JVMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_LifeScienceJVsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_TorreyPinesScienceCenterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_BritanniaBiotechGatewayLPMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_LASDKLPMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_MbkJvMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_DevelopmentJVsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_VintageIlDevelopmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_WaldwickMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_OtayRanchMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_MbkDevelopmentJvMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_MedicalOfficeJVsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_HCPVenturesIVLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_HCPVenturesIIILLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_SuburbanPropertiesLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_KAndYMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |